1. Home
  2. BOLD vs NSYS Comparison

BOLD vs NSYS Comparison

Compare BOLD & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • NSYS
  • Stock Information
  • Founded
  • BOLD 2018
  • NSYS 1981
  • Country
  • BOLD United States
  • NSYS United States
  • Employees
  • BOLD N/A
  • NSYS N/A
  • Industry
  • BOLD
  • NSYS Industrial Machinery/Components
  • Sector
  • BOLD
  • NSYS Technology
  • Exchange
  • BOLD Nasdaq
  • NSYS Nasdaq
  • Market Cap
  • BOLD 24.4M
  • NSYS 22.3M
  • IPO Year
  • BOLD 2024
  • NSYS N/A
  • Fundamental
  • Price
  • BOLD $1.17
  • NSYS $8.86
  • Analyst Decision
  • BOLD Buy
  • NSYS
  • Analyst Count
  • BOLD 4
  • NSYS 0
  • Target Price
  • BOLD $4.00
  • NSYS N/A
  • AVG Volume (30 Days)
  • BOLD 80.0K
  • NSYS 6.3K
  • Earning Date
  • BOLD 08-05-2025
  • NSYS 08-07-2025
  • Dividend Yield
  • BOLD N/A
  • NSYS N/A
  • EPS Growth
  • BOLD N/A
  • NSYS N/A
  • EPS
  • BOLD N/A
  • NSYS N/A
  • Revenue
  • BOLD N/A
  • NSYS $117,597,000.00
  • Revenue This Year
  • BOLD N/A
  • NSYS N/A
  • Revenue Next Year
  • BOLD N/A
  • NSYS N/A
  • P/E Ratio
  • BOLD N/A
  • NSYS N/A
  • Revenue Growth
  • BOLD N/A
  • NSYS N/A
  • 52 Week Low
  • BOLD $1.00
  • NSYS $7.25
  • 52 Week High
  • BOLD $4.72
  • NSYS $13.90
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 51.81
  • NSYS 59.07
  • Support Level
  • BOLD $1.09
  • NSYS $8.05
  • Resistance Level
  • BOLD $1.19
  • NSYS $8.45
  • Average True Range (ATR)
  • BOLD 0.05
  • NSYS 0.25
  • MACD
  • BOLD -0.00
  • NSYS 0.06
  • Stochastic Oscillator
  • BOLD 82.76
  • NSYS 100.00

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

Share on Social Networks: